We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

53 hedge funds and large institutions have $82.8M invested in Rapid Micro Biosystems in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 5253 (+1)

1.3% less ownership

Funds ownership: 71.75%70.45% (-1.3%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

26% less capital invested

Capital invested by funds: $112M → $82.8M (-$29.3M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
0.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
9
Increased
10
Reduced
18
Closed
8
Calls
Puts
Net Calls
Net Calls Change

RPID Hedge Fund Activity: Q3 2022 in Review

53 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q3 2022, worth a combined $82.8M — down 26% from $112M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new RPID positions and 8 closed out — a net gain of 1 holder — while 10 added to existing stakes and 18 trimmed.

The largest buyer was Vanguard Group, adding an estimated $193K. The largest seller was T. Rowe Price Associates, cutting an estimated $10M.

  • 53 institutional investors held Rapid Micro Biosystems (RPID) as of Q3 2022, up from 52 in Q2 2022.
  • Funds reported $82.8M of Rapid Micro Biosystems stock for Q3 2022, down 26% quarter-over-quarter.
  • 9 funds opened new Rapid Micro Biosystems positions in Q3 2022 and 8 closed out, a net change of +1 holder.
  • The largest Rapid Micro Biosystems buyer in Q3 2022 was Vanguard Group, an estimated $193K added.
  • The largest Rapid Micro Biosystems seller in Q3 2022 was T. Rowe Price Associates, an estimated $10M sold.

Based on aggregated 13F filings for Q3 2022.